Fenster schließen  |  Fenster drucken

...

Business Development

Sernova is committed to business development activities to in-license complementary technologies to expand Sernova’s product development portfolio, and intellectual property base that is of key importance for partnering activities. This work is also expected to result in corporate partnerships to develop products with other Companies. Furthermore, Sernova is actively pursuing potential pharmaceutical and medical device corporate partners to develop and market its products.:eek::eek::eek:

...


Quelle: MD&A vom 29.6.2015
 
aus der Diskussion: Sernova – Patentierte Zelltaschen mit Schutzschild gegen die Immunabwehr !
Autor (Datum des Eintrages): techinvestor69  (29.06.15 20:15:14)
Beitrag: 35 von 8,451 (ID:50076243)
Alle Angaben ohne Gewähr © wallstreetONLINE